MedTrace Logo

Magnetic Marker Monitoring (MMM) Study With Gel Matrix Tablets Under Fasting and Fed Conditions

NCT01224587 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2010-11-04

No results posted yet for this study

Summary

The purpose of this study is to monitor the gastrointestinal transport of eroding gel matrix placebo tablets in healthy male volunteers under fasting and fed conditions. The method which is used is an imaging technique.

Conditions

  • Magnetic Marker Monitoring
  • Gastrointestinal-transport
  • Gastric Emptying Time
  • Small Intestinal Transit Time
  • Time for Colon Arrival
  • Food Effect

Interventions

DRUG

D1000078

Oral, one single dose

DRUG

D1000082

Oral, one single dose

DRUG

D1000083

Oral, one single dose

DRUG

D1000085

Oral, one single dose

Sponsors & Collaborators

Principal Investigators

  • Frank Donath, MD · Socra Tec R&D GmbH, Clinical Pharmacology Unit

  • Maria Anschütz · Socra Tec R&D GmbH

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01224587 on ClinicalTrials.gov